IP Library › Granted Patent US 10,117,606
Granted Patent B2
US 10,117,606 · App. 14/730,077 · Granted Nov 6, 2018

Method and apparatus for detecting false hypoglycemic conditions

Inventors: Benjamin Jay Feldman (Berkeley, CA); Adam Heller (Austin, TX); Namvar Kiaie (Danville, CA)
Assignee: Abbott Diabetes Care Inc.
A61B5/14532A61B5/01A61B5/1451A61B5/14546A61B5/14865A61B5/746
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,117,606
App. No.
14/730,077
Filed
Jun 3, 2015
Granted
Nov 6, 2018
Kind
B2
Art Unit
3791
USPC
600/365
Abstract

Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.

Claims (21)

1. A system, comprising:

an analyte sensor positioned in fluid contact with interstitial fluid under a skin layer and configured to generate signals corresponding to a monitored analyte level in the interstitial fluid;

sensor electronics electrically coupled to the analyte sensor and configured to generate analyte data based on the signals generated by the analyte sensor; and

a data receiver configured to receive the generated analyte data from the sensor electronics, the data receiver configured to trigger a hold assertion function to temporarily prevent the assertion of a programmed notification after the programmed notification has initiated when a rate of change of the monitored analyte level determined from the generated analyte data exceeds a predetermined analyte threshold during a monitoring time period, and to assert the programmed notification when the rate of change of a monitored temperature exceeds a predetermined temperature threshold during the monitoring time period.

2. The system of claim 1 , wherein the predetermined analyte threshold includes a decreasing rate of the analyte level of approximately 2 mg/dL/minute.

3. The system of claim 1 , wherein the asserted programmed notification indicates a hypoglycemic condition.

4. The system of claim 1 , wherein the data receiver is configured to assert the programmed notification when a direction of the analyte level rate of change and a direction of the monitored temperature rate of change are the same.

5. The system of claim 1 , wherein the monitored analyte level includes one or more of glucose level or lactate level.

6. The system of claim 1 , wherein the data receiver is configured to receive monitored temperature information to determine the rate of change of the monitored temperature.

7. The system of claim 1 , wherein the predetermined temperature threshold includes a decreasing rate of a temperature level of approximately 2° C./15 minutes.

8. The system of claim 1 , wherein the analyte sensor includes a plurality of electrodes including a working electrode comprising an analyte-responsive enzyme bonded to a polymer disposed on the working electrode.

9. The system of claim 8 , wherein the analyte-responsive enzyme is chemically bonded to the polymer disposed on the working electrode.

10. The system of claim 8 , wherein the working electrode comprises a mediator bonded to the polymer disposed on the working electrode.

11. The system of claim 10 , wherein the mediator is crosslinked with the polymer disposed on the working electrode.

12. The system of claim 1 , wherein the analyte sensor includes a plurality of electrodes including a working electrode comprising a mediator bonded to a polymer disposed on the working electrode.

13. A system, comprising

sensor electronics configured to receive signals from an analyte sensor in fluid contact with interstitial fluid, and to generate analyte data corresponding to a monitored analyte level in interstitial fluid; and

a data receiver configured to receive the generated analyte data from the sensor electronics, the data receiver configured to temporarily prevent the assertion of a programmed notification after the programmed notification has initiated when a rate of change of the monitored analyte level determined from the generated analyte data exceeds a predetermined analyte threshold during a monitoring time period, but to assert the programmed notification when a rate of change of a monitored temperature exceeds a predetermined temperature threshold during the monitoring time period.

14. The system of claim 13 , wherein the predetermined analyte threshold includes a decreasing rate of the analyte level of approximately 2 mg/dL/minute.

15. The system of claim 13 , wherein the predetermined temperature threshold includes a decreasing rate of a temperature level of approximately 2° C./15 minutes.

16. The system of claim 13 , wherein the data receiver is configured to assert the programmed notification when a direction of the analyte level rate of change and a direction of the temperature level rate of change are the same.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2015
From: FELDMAN, BENJAMIN JAY; HELLER, ADAM; KIAIE, NAMVAR
To: ABBOTT DIABETES CARE INC.
Reel/Frame 035781/0274 →
Continuity (4)
Continuation 13477026 · May 21, 2012
Division 12916481 · Oct 29, 2010
Provisional Application 61256920 · Oct 30, 2009
Related Publication 20150265192A1 · Sep 24, 2015
Cited By (6)
US 12,232,851 US 12,478,298 US 12,502,107 US 12,514,471 US 12,521,022 US 12,558,036